The MR CLEAN trial demonstrated the effectiveness of physical removal of blood clots in improving outcome for stroke patients. The HERMES collaboration found that patients with large ischemic core volumes can still benefit from thrombectomy, while the ACTION study showed promise with intravenous natalizumab for acute ischemic stroke. O...
The European Stroke Organisation Conference highlighted major clinical trials on treating patients who suffer a stroke caused by bleeding into the brain. Studies found that platelet transfusion may be harmful and is not beneficial for patients taking aspirin. Additionally, tissue plasminogen activator (r-tPA) treatment was shown to red...
Researchers presented findings from the SOCRATES trial, which tested ticagrelor against aspirin for reducing further strokes. The study showed that ticagrelor did not significantly reduce second strokes or death. In contrast, a lower dose of intravenous rtPA reduced serious brain bleeding by two-thirds and improved survival rates. Addi...